Biosynthesis and Pharmacological Activities of Flavonoids, Triterpene Saponins and Polysaccharides Derived from Astragalus membranaceus
- PMID: 37446680
- PMCID: PMC10343288
- DOI: 10.3390/molecules28135018
Biosynthesis and Pharmacological Activities of Flavonoids, Triterpene Saponins and Polysaccharides Derived from Astragalus membranaceus
Abstract
Astragalus membranaceus (A. membranaceus), a well-known traditional herbal medicine, has been widely used in ailments for more than 2000 years. The main bioactive compounds including flavonoids, triterpene saponins and polysaccharides obtained from A. membranaceus have shown a wide range of biological activities and pharmacological effects. These bioactive compounds have a significant role in protecting the liver, immunomodulation, anticancer, antidiabetic, antiviral, antiinflammatory, antioxidant and anti-cardiovascular activities. The flavonoids are initially synthesized through the phenylpropanoid pathway, followed by catalysis with corresponding enzymes, while the triterpenoid saponins, especially astragalosides, are synthesized through the universal upstream pathways of mevalonate (MVA) and methylerythritol phosphate (MEP), and the downstream pathway of triterpenoid skeleton formation and modification. Moreover, the Astragalus polysaccharide (APS) possesses multiple pharmacological activities. In this review, we comprehensively discussed the biosynthesis pathway of flavonoids and triterpenoid saponins, and the structural features of polysaccharides in A. membranaceus. We further systematically summarized the pharmacological effects of bioactive ingredients in A. membranaceus, which laid the foundation for the development of clinical candidate agents. Finally, we proposed potential strategies of heterologous biosynthesis to improve the industrialized production and sustainable supply of natural products with pharmacological activities from A. membranaceus, thereby providing an important guide for their future development trend.
Keywords: Astragalus membranaceus; biosynthesis; flavonoids; pharmacological activity; polysaccharides; triterpene saponins.
Conflict of interest statement
The authors declare no conflict of interest.
Figures





Similar articles
-
Pharmacokinetics of two triterpenoid saponins and three flavonoids in Astragalus membranaceus leaves by UHPLC-MS/MS.J Pharm Biomed Anal. 2024 Dec 15;251:116419. doi: 10.1016/j.jpba.2024.116419. Epub 2024 Aug 15. J Pharm Biomed Anal. 2024. PMID: 39154580
-
Review of the botanical characteristics, phytochemistry, and pharmacology of Astragalus membranaceus (Huangqi).Phytother Res. 2014 Sep;28(9):1275-83. doi: 10.1002/ptr.5188. Epub 2014 Aug 2. Phytother Res. 2014. PMID: 25087616 Review.
-
Astragaloside IV derived from Astragalus membranaceus: A research review on the pharmacological effects.Adv Pharmacol. 2020;87:89-112. doi: 10.1016/bs.apha.2019.08.002. Epub 2019 Dec 18. Adv Pharmacol. 2020. PMID: 32089240 Review.
-
Research progress of Astragalus membranaceus in treating peritoneal metastatic cancer.J Ethnopharmacol. 2023 Apr 6;305:116086. doi: 10.1016/j.jep.2022.116086. Epub 2022 Dec 29. J Ethnopharmacol. 2023. PMID: 36587879 Review.
-
Research Progress on the Anti-Cancer Effects of Astragalus membranaceus Saponins and Their Mechanisms of Action.Molecules. 2024 Jul 18;29(14):3388. doi: 10.3390/molecules29143388. Molecules. 2024. PMID: 39064966 Free PMC article. Review.
Cited by
-
Astragalus membranaceus: A Review of Its Antitumor Effects on Non-Small Cell Lung Cancer.Cancer Manag Res. 2024 Jul 25;16:909-919. doi: 10.2147/CMAR.S466633. eCollection 2024. Cancer Manag Res. 2024. PMID: 39081698 Free PMC article. Review.
-
Exploratory review on the effect of Astragalus mongholicus on signaling pathways.Front Pharmacol. 2024 Dec 11;15:1510307. doi: 10.3389/fphar.2024.1510307. eCollection 2024. Front Pharmacol. 2024. PMID: 39726784 Free PMC article. Review.
-
Diabetes cardiomyopathy: targeted regulation of mitochondrial dysfunction and therapeutic potential of plant secondary metabolites.Front Pharmacol. 2024 Jul 9;15:1401961. doi: 10.3389/fphar.2024.1401961. eCollection 2024. Front Pharmacol. 2024. PMID: 39045049 Free PMC article. Review.
-
Astragaloside IV inhibits nasopharyngeal carcinoma progression by suppressing the SATB2/Wnt signaling axis.Toxicol Res (Camb). 2025 Apr 2;14(2):tfaf047. doi: 10.1093/toxres/tfaf047. eCollection 2025 Apr. Toxicol Res (Camb). 2025. PMID: 40177383 Free PMC article.
-
Inherently imperfect, inherently evolving - The pursuit of precision through biomarkers.Biomed J. 2025 Feb;48(1):100839. doi: 10.1016/j.bj.2025.100839. Epub 2025 Feb 25. Biomed J. 2025. PMID: 40015558 Free PMC article.
References
-
- Li Y., Guo S., Zhu Y., Yan H., Qian D.W., Wang H.Q., Yu J.Q., Duan J.A. Comparative analysis of twenty-five compounds in different parts of Astragalus membranaceus var. mongholicus and Astragalus membranaceus by UPLC-MS/MS. J. Pharm. Anal. 2019;9:392–399. doi: 10.1016/j.jpha.2019.06.002. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous